Shares of Molina Healthcare, Inc. (NYSE:MOH) fell 0.7% during trading on Wednesday after Morgan Stanley lowered their price target on the stock from $97.00 to $94.00. Morgan Stanley currently has an overweight rating on the stock. Molina Healthcare traded as low as $79.06 and last traded at $83.00. 1,106,881 shares changed hands during trading, a decline of 18% from the average session volume of 1,343,793 shares. The stock had previously closed at $82.43.
Several other brokerages also recently commented on MOH. JPMorgan Chase & Co. upgraded shares of Molina Healthcare from a “neutral” rating to an “overweight” rating in a research report on Tuesday, January 16th. Leerink Swann raised their price objective on shares of Molina Healthcare from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, January 9th. Zacks Investment Research upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Monday, November 6th. ValuEngine downgraded shares of Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Finally, Goldman Sachs Group began coverage on shares of Molina Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price objective on the stock. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $71.21.
In other news, Director Garrey Carruthers sold 1,300 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $75.66, for a total value of $98,358.00. Following the sale, the director now directly owns 7,016 shares in the company, valued at approximately $530,830.56. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director John C. Molina sold 19,433 shares of the business’s stock in a transaction dated Thursday, December 27th. The stock was sold at an average price of $77.22, for a total transaction of $1,500,616.26. Following the completion of the sale, the director now owns 414,915 shares in the company, valued at $32,039,736.30. The disclosure for this sale can be found here. Over the last quarter, insiders sold 776,455 shares of company stock worth $61,614,520. 6.20% of the stock is currently owned by insiders.
The company has a debt-to-equity ratio of 1.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market capitalization of $4,660.00, a price-to-earnings ratio of -15.50, a price-to-earnings-growth ratio of 1.02 and a beta of 1.10.
WARNING: “Molina Healthcare (MOH) Stock Price Down 0.7% Following Analyst Downgrade” was originally reported by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.com-unik.info/2018/02/08/molina-healthcare-moh-stock-price-down-0-7-following-analyst-downgrade.html.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.